Literature DB >> 28807980

CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation.

Ming Bai1, Ricardo Grieshaber-Bouyer1, Junxia Wang1, Angela B Schmider2, Zachary S Wilson3, Liling Zeng4, Olha Halyabar1,5, Matthew D Godin2, Hung N Nguyen1, Anaïs Levescot1, Pierre Cunin1, Craig T Lefort3, Roy J Soberman2, Peter A Nigrovic1,5.   

Abstract

CD177 is a glycosylphosphatidylinositol (GPI)-anchored protein expressed by a variable proportion of human neutrophils that mediates surface expression of the antineutrophil cytoplasmic antibody antigen proteinase 3. CD177 associates with β2 integrins and recognizes platelet endothelial cell adhesion molecule 1 (PECAM-1), suggesting a role in neutrophil migration. However, CD177pos neutrophils exhibit no clear migratory advantage in vivo, despite interruption of in vitro transendothelial migration by CD177 ligation. We sought to understand this paradox. Using a PECAM-1-independent transwell system, we found that CD177pos and CD177neg neutrophils migrated comparably. CD177 ligation selectively impaired migration of CD177pos neutrophils, an effect mediated through immobilization and cellular spreading on the transwell membrane. Correspondingly, CD177 ligation enhanced its interaction with β2 integrins, as revealed by fluorescence lifetime imaging microscopy, leading to integrin-mediated phosphorylation of Src and extracellular signal-regulated kinase (ERK). CD177-driven cell activation enhanced surface β2 integrin expression and affinity, impaired internalization of integrin attachments, and resulted in ERK-mediated attenuation of chemokine signaling. We conclude that CD177 signals in a β2 integrin-dependent manner to orchestrate a set of activation-mediated mechanisms that impair human neutrophil migration.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28807980      PMCID: PMC5680608          DOI: 10.1182/blood-2017-03-768507

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Expression of human neutrophil antigen-2a (NB1) is increased in pregnancy.

Authors:  Lorraine Caruccio; Maria Bettinotti; Kazuhiko Matsuo; Victoria Sharon; David Stroncek
Journal:  Transfusion       Date:  2003-03       Impact factor: 3.157

Review 2.  Neutrophil heterogeneity: implications for homeostasis and pathogenesis.

Authors:  Carlos Silvestre-Roig; Andres Hidalgo; Oliver Soehnlein
Journal:  Blood       Date:  2016-03-21       Impact factor: 22.113

3.  NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils.

Authors:  Sibylle von Vietinghoff; Gisela Tunnemann; Claudia Eulenberg; Maren Wellner; M Cristina Cardoso; Friedrich C Luft; Ralph Kettritz
Journal:  Blood       Date:  2007-01-23       Impact factor: 22.113

4.  Membrane proteinase 3 expression and ANCA-induced neutrophil activation.

Authors:  Adrian Schreiber; Friedrich C Luft; Ralph Kettritz
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

5.  Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor.

Authors:  D F Stroncek; W Jaszcz; G P Herr; M E Clay; J McCullough
Journal:  Transfusion       Date:  1998-07       Impact factor: 3.157

6.  NB1, a new neutrophil-specific antigen involved in the pathogenesis of neonatal neutropenia.

Authors:  P Lalezari; G B Murphy; F H Allen
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

7.  Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.

Authors:  N Hu; J Westra; M G Huitema; M Bijl; E Brouwer; C A Stegeman; P Heeringa; P C Limburg; C G M Kallenberg
Journal:  Arthritis Rheum       Date:  2009-05

8.  Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool.

Authors:  L Halbwachs-Mecarelli; G Bessou; P Lesavre; S Lopez; V Witko-Sarsat
Journal:  FEBS Lett       Date:  1995-10-23       Impact factor: 4.124

9.  Surface receptor CD177/NB1 does not confer a recruitment advantage to neutrophilic granulocytes during human peritonitis.

Authors:  Le Wang; Shuwang Ge; Andina Agustian; Marcus Hiss; Hermann Haller; Sibylle von Vietinghoff
Journal:  Eur J Haematol       Date:  2013-03-22       Impact factor: 2.997

10.  Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases.

Authors:  Xiaowen Liu; Bo Ma; Asrar B Malik; Haiyang Tang; Tao Yang; Bo Sun; Gang Wang; Richard D Minshall; Yan Li; Yong Zhao; Richard D Ye; Jingsong Xu
Journal:  Nat Immunol       Date:  2012-03-25       Impact factor: 25.606

View more
  45 in total

Review 1.  Neutrophil Diversity in Health and Disease.

Authors:  Carlos Silvestre-Roig; Zvi G Fridlender; Michael Glogauer; Patrizia Scapini
Journal:  Trends Immunol       Date:  2019-05-31       Impact factor: 16.687

2.  Differential attenuation of β2 integrin-dependent and -independent neutrophil migration by Ly6G ligation.

Authors:  Pierre Cunin; Pui Y Lee; Edy Kim; Angela B Schmider; Nathalie Cloutier; Alexandre Pare; Matthias Gunzer; Roy J Soberman; Steve Lacroix; Eric Boilard; Craig T Lefort; Peter A Nigrovic
Journal:  Blood Adv       Date:  2019-02-12

3.  Analysis of Keratinocytic Exosomes from Diabetic and Nondiabetic Mice by Charge Detection Mass Spectrometry.

Authors:  Brooke A Brown; Poornachander R Guda; Xuyao Zeng; Adam Anthony; Andrew Couse; Lauren F Barnes; Edie M Sharon; Jonathan C Trinidad; Chandan K Sen; Martin F Jarrold; Subhadip Ghatak; David E Clemmer
Journal:  Anal Chem       Date:  2022-06-14       Impact factor: 8.008

Review 4.  Genetic Factors and Their Role in the Pathogenesis of Biliary Atresia.

Authors:  Li-Na Wu; Zhi-Jun Zhu; Li-Ying Sun
Journal:  Front Pediatr       Date:  2022-06-29       Impact factor: 3.569

5.  Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint.

Authors:  Ricardo Grieshaber-Bouyer; Tarik Exner; Nicolaj S Hackert; Felix A Radtke; Scott A Jelinsky; Olha Halyabar; Alexandra Wactor; Elham Karimizadeh; Joseph Brennan; Jorge Schettini; Helena Jonsson; Deepak A Rao; Lauren A Henderson; Carsten Müller-Tidow; Hanns-Martin Lorenz; Guido Wabnitz; James A Lederer; Angela Hadjipanayis; Peter A Nigrovic
Journal:  Ann Rheum Dis       Date:  2022-02-15       Impact factor: 27.973

6.  Gene Expression Signature in Patients With Symptomatic Peripheral Artery Disease.

Authors:  Jonathan D Newman; MacIntosh G Cornwell; Hua Zhou; Caron Rockman; Adriana Heguy; Yajaira Suarez; Henry S Cheng; Mark W Feinberg; Judith S Hochman; Kelly V Ruggles; Jeffrey S Berger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-04       Impact factor: 8.311

7.  An integrative network analysis framework for identifying molecular functions in complex disorders examining major depressive disorder as a test case.

Authors:  Anup Mammen Oommen; Stephen Cunningham; Páraic S O'Súilleabháin; Brian M Hughes; Lokesh Joshi
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

Review 8.  Microphysiological Systems for Studying Cellular Crosstalk During the Neutrophil Response to Infection.

Authors:  Isaac M Richardson; Christopher J Calo; Laurel E Hind
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

9.  CFP is a prognostic biomarker and correlated with immune infiltrates in Gastric Cancer and Lung Cancer.

Authors:  Guoliang Cui; Le Geng; Li Zhu; Zhenyan Lin; Xuan Liu; Zhengyue Miao; Jintao Jiang; Xiaoke Feng; Fei Wei
Journal:  J Cancer       Date:  2021-04-12       Impact factor: 4.207

10.  TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca2+/CaMKII/Nrf2 signaling pathway.

Authors:  Zhongyang Lv; Xingquan Xu; Ziying Sun; Yannick Xiaofan Yang; Hu Guo; Jiawei Li; Kuoyang Sun; Rui Wu; Jia Xu; Qing Jiang; Shiro Ikegawa; Dongquan Shi
Journal:  Cell Death Dis       Date:  2021-05-18       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.